Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaozhen Zhitong Gel is a topical botanical drug candidate developed by Suzhou Yusen New Drug Development Co., Ltd. for the treatment of herpes zoster (shingles). It is specifically designed to address the 'Liver Meridian Damp-Heat Syndrome' as defined in Traditional Chinese Medicine (TCM). The formulation is a gel intended for local application to skin lesions to promote the resolution of rashes and provide relief from acute pain associated with the varicella-zoster virus infection. The drug has been evaluated in Phase 2 clinical trials in China to determine its optimal dosage, efficacy, and safety profile in patients with herpes zoster.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaozhen Zhitong Gel.